EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:9566 - thioridazine
| Formula | C21H26N2S2 |
| Net Charge | 0 |
| Average Mass | 370.587 |
| Monoisotopic Mass | 370.15374 |
| SMILES | CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2 |
| InChI | InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3 |
| InChIKey | KLBQZWRITKRQQV-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of trypanothione-disulfide reductase (EC 1.8.1.12). dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. EC 3.4.21.26 (prolyl oligopeptidase) inhibitor Any EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of prolyl oligopeptidase (EC 3.4.21.26). alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. first generation antipsychotic Antipsychotic drugs which can have different modes of action but which tend to be more likely than second generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements; such body movements can become permanent even after treatment has ceased. dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| thioridazine (CHEBI:9566) has part methylsulfanyl group (CHEBI:48563) |
| thioridazine (CHEBI:9566) has role antidepressant (CHEBI:35469) |
| thioridazine (CHEBI:9566) has role antineoplastic agent (CHEBI:35610) |
| thioridazine (CHEBI:9566) has role anxiolytic drug (CHEBI:35474) |
| thioridazine (CHEBI:9566) has role dopaminergic antagonist (CHEBI:48561) |
| thioridazine (CHEBI:9566) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| thioridazine (CHEBI:9566) has role EC 3.4.21.26 (prolyl oligopeptidase) inhibitor (CHEBI:76779) |
| thioridazine (CHEBI:9566) has role first generation antipsychotic (CHEBI:65190) |
| thioridazine (CHEBI:9566) has role H1-receptor antagonist (CHEBI:37955) |
| thioridazine (CHEBI:9566) has role serotonergic antagonist (CHEBI:48279) |
| thioridazine (CHEBI:9566) has role α-adrenergic antagonist (CHEBI:37890) |
| thioridazine (CHEBI:9566) is a phenothiazines (CHEBI:38093) |
| thioridazine (CHEBI:9566) is a piperidines (CHEBI:26151) |
| Incoming Relation(s) |
| thioridazine hydrochloride (CHEBI:48566) has part thioridazine (CHEBI:9566) |
| IUPAC Name |
|---|
| 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine |
| INNs | Source |
|---|---|
| thioridazine | ChemIDplus |
| thioridazinum | ChemIDplus |
| tioridazina | ChemIDplus |
| Synonyms | Source |
|---|---|
| 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine | IUPHAR |
| 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine | ChemIDplus |
| 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine | ChemIDplus |
| Novoridazine | ChEMBL |
| Thioridazin | DrugBank |
| Thioridazine prolongatum | ChEMBL |
| Brand Names | Source |
|---|---|
| Mallorol | DrugBank |
| Malloryl | IUPHAR |
| Meleril | DrugBank |
| Mellaril | DrugBank |
| Mellaril-S | KEGG DRUG |
| Mellerets | IUPHAR |
| Manual Xrefs | Databases |
|---|---|
| 2637 | DrugCentral |
| D00373 | KEGG DRUG |
| DB00679 | DrugBank |
| HMDB0014817 | HMDB |
| LSM-1863 | LINCS |
| Thioridazine | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:94457 | Reaxys |
| CAS:50-52-2 | ChemIDplus |
| Citations |
|---|